|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
10,820,000 |
Market
Cap: |
1.30(B) |
Last
Volume: |
401,241 |
Avg
Vol: |
400,142 |
52
Week Range: |
$115.55 - $119.99 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Heska sells veterinary and animal health diagnostic and specialty products. Co.'s primary focus is on the canine and feline healthcare space. Co.'s business is composed of two segments: North America and International. Co.'s main product categories sold in both segments include: Point of Care laboratory instruments and consumables; digital imaging diagnostic instruments, software and services; digital cytology services; local and cloud-based data services; allergy testing and immunotherapy; and single use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
14,458 |
Total Buy Value |
$0 |
$0 |
$0 |
$851,078 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
2 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Mcginley Michael J |
Presi, Biologic. & Pharm. |
|
2016-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
14,896 |
30,855 |
|
- |
|
Napolitano Jason A |
EVP, COO, CFO and Secretary |
|
2016-03-02 |
4 |
D |
$33.64 |
$33,775 |
D/D |
(1,004) |
66,627 |
|
- |
|
Napolitano Jason A |
EVP, COO, CFO and Secretary |
|
2016-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
15,731 |
67,631 |
|
- |
|
Napolitano Jason A |
EVP, COO, CFO and Secretary |
|
2016-01-27 |
4 |
AS |
$37.00 |
$555,000 |
D/D |
(15,000) |
51,900 |
|
- |
|
Napolitano Jason A |
EVP, COO, CFO and Secretary |
|
2015-12-29 |
4/A |
AS |
$40.00 |
$148,128 |
D/D |
(3,700) |
66,900 |
|
- |
|
Napolitano Jason A |
EVP, COO, CFO and Secretary |
|
2015-12-29 |
4 |
S |
$40.00 |
$148,128 |
D/D |
(3,700) |
66,900 |
|
- |
|
Napolitano Jason A |
EVP, COO, CFO and Secretary |
|
2015-12-22 |
4 |
OE |
$4.40 |
$4,400 |
D/D |
1,000 |
70,600 |
|
- |
|
Napolitano Jason A |
EVP, COO, CFO and Secretary |
|
2015-12-15 |
4 |
D |
$35.73 |
$518,085 |
D/D |
(14,500) |
69,600 |
|
- |
|
Napolitano Jason A |
EVP, COO, CFO and Secretary |
|
2015-12-15 |
4 |
OE |
$12.50 |
$325,000 |
D/D |
26,000 |
84,100 |
|
- |
|
Wilson Kevin S. |
CEO and President |
|
2015-12-03 |
4 |
S |
$35.50 |
$156,200 |
I/I |
(4,400) |
13,432 |
|
- |
|
Wilson Kevin S. |
CEO and President |
|
2015-12-02 |
4 |
S |
$35.50 |
$56,800 |
I/I |
(1,600) |
14,532 |
|
- |
|
Wisnewski Nancy |
EVP, Prod. Dev & Cust. Support |
|
2015-12-01 |
4 |
D |
$35.55 |
$225,067 |
D/D |
(6,331) |
20,764 |
|
- |
|
Wisnewski Nancy |
EVP, Prod. Dev & Cust. Support |
|
2015-12-01 |
4 |
OE |
$12.50 |
$162,500 |
D/D |
13,000 |
27,095 |
|
- |
|
Mcginley Michael J |
Presi, Biologic. & Pharm. |
|
2015-11-25 |
4 |
S |
$33.62 |
$32,210 |
D/D |
(958) |
15,928 |
|
- |
|
Mcginley Michael J |
Presi, Biologic. & Pharm. |
|
2015-11-25 |
4 |
OE |
$12.50 |
$11,975 |
D/D |
958 |
15,984 |
|
- |
|
Mcginley Michael J |
Presi, Biologic. & Pharm. |
|
2015-11-24 |
4 |
S |
$33.25 |
$47,558 |
D/D |
(1,427) |
15,928 |
|
- |
|
Mcginley Michael J |
Presi, Biologic. & Pharm. |
|
2015-11-24 |
4 |
OE |
$12.50 |
$17,838 |
D/D |
1,427 |
17,355 |
|
- |
|
Wilson Kevin S. |
CEO and President |
|
2015-11-18 |
4 |
S |
$35.00 |
$210,000 |
I/I |
(6,000) |
14,932 |
|
- |
|
Mcginley Michael J |
Presi, Biologic. & Pharm. |
|
2015-11-17 |
4 |
S |
$35.00 |
$250,947 |
D/D |
(7,114) |
15,928 |
|
- |
|
Mcginley Michael J |
Presi, Biologic. & Pharm. |
|
2015-11-17 |
4 |
OE |
$12.50 |
$88,925 |
D/D |
7,114 |
23,042 |
|
- |
|
Napolitano Jason A |
Chief Financial Officer |
|
2015-09-11 |
4 |
AS |
$33.51 |
$56,933 |
D/D |
(1,699) |
58,100 |
|
- |
|
Grieve Robert B |
Executive Chair |
|
2015-08-31 |
4 |
S |
$33.75 |
$330,683 |
D/D |
(9,798) |
101,690 |
|
- |
|
Grieve Robert B |
Executive Chair |
|
2015-08-31 |
4 |
OE |
$12.50 |
$122,475 |
D/D |
9,798 |
111,488 |
|
- |
|
Napolitano Jason A |
Chief Financial Officer |
|
2015-08-31 |
4 |
S |
$33.49 |
$167,883 |
D/D |
(4,998) |
59,799 |
|
- |
|
Grieve Robert B |
Executive Chair |
|
2015-08-28 |
4 |
S |
$33.95 |
$44,135 |
D/D |
(1,300) |
101,690 |
|
- |
|
465 Records found
|
|
Page 16 of 19 |
|
|